Solving the problem of side effects of siRNA-based drugs for the treatment of genetic diseases
A formamide modification (yellow) to a siRNA therapeutic agent (blue) prevents it from binding to non-targeted mRNA, allowing treatment with ...
A formamide modification (yellow) to a siRNA therapeutic agent (blue) prevents it from binding to non-targeted mRNA, allowing treatment with ...
Credit: CC0 Public Domain Researchers at Weill Cornell Medicine used artificial intelligence to identify drug targets based on mapping regulatory ...
Credit: Unsplash/CC0 Public Domain More than two decades ago, a research team in the lab of David Hafler, a researcher ...
Credit: Unsplash/CC0 Public Domain Tuberculosis (TB) is a daunting scourge. It is the leading cause of death from infectious disease ...
Modified peptide derived from natural CART peptide. After repeated administration to mice with obesity and prediabetes, the mice began to ...
This diagram illustrates the typical environment of a digital wallet and credit card. Credit: Raja Hasnain Anwar, UMass Amherst It’s ...
Jeffrey Rathmell, Ph.D., left, and Andrew Patterson, Ph.D., have discovered a new set of metabolic genes that are important for ...
UBXN3B is crucial for the survival of mature B cells. Immunofluorescence staining of apoptotic cells (TUNEL) and B cells (CD19) ...
Cells expressing a mutant protein, TDP-43, involved in MND pathology. Credit: Dr Rebecca San Gil from the Queensland Brain Institute ...
Proteins are natural polymers that govern biological processes at all levels. A new study presents artificial proteins made using modern ...
© 2023 Manhattan Tribune -By Millennium Press
© 2023 Manhattan Tribune -By Millennium Press